株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

モバイルヘルス (mヘルス) 技術:世界市場の見通し

Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017

発行 CBR Pharma Insights 商品コード 524532
出版日 ページ情報 英文 67 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
モバイルヘルス (mヘルス) 技術:世界市場の見通し Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017
出版日: 2017年06月01日 ページ情報: 英文 67 Pages
概要

当レポートでは、モバイルヘルス (mヘルス) 情勢について取り上げ、mヘルスの利用に関する経験と見解のほか、現在・将来の利用に関する主要動向 (特に製薬業界) について検証して、体系的な情報を提供しています。

第1章 目次

第2章 mヘルス技術の概要

  • mヘルス技術とは
  • mヘルス技術が提供できるサービスの種類
  • mヘルス技術の主な目的
  • mヘルスの資金・提供に関与する主要ステークホルダー
  • mヘルス市場空間における主な市場セグメント
  • mヘルス技術の利用における普及率

第3章 世界のmヘルス市場:主要促進要因・抑制要因

  • 主要促進要因
  • 主要抑制要因

第4章 mヘルス:R&D・商業戦略

  • 製薬業界におけるmヘルス技術の役割
  • mヘルス技術を現在活用している特定分野
  • 今後5年間でmヘルスが影響を与える分野

第5章 mヘルス技術における最も有望な地域市場

  • 世界のモバイル普及における重要動向
  • 新興経済国

第6章 mヘルスイニシアチブの効果的導入に対する戦略的考察

  • 重要な検討事項
  • その他

第7章 mヘルス技術の結論と将来の見通し

第8章 付録

目次
Product Code: GBI080CBR

Summary

mHealth is often regarded as a branch of eHealth, which has been defined by the European Commission as "The use of modern information and communication technologies to meet needs of citizens, patients, healthcare professionals, healthcare providers, as well as policy makers." Within this, the mHealth branch focuses specifically on the use of mobile technology. Rapid advances in new mobile devices, the expansion of communication network coverage and the reduction in the retail price of wireless technologies have all helped in making mHealth solutions and services a reality.

The uptake of mHealth technologies will increase in the near future as the overall healthcare industry continues to shift towards value-based medicine, and the need to clearly demonstrate the value and effectiveness of medical interventions grows. Support from healthcare professionals (HCP), reimbursement entities and government agencies will also increase as the body of literature documenting the wide range of benefits of mHealth continues to grow. Furthermore, the continued acceleration of mobile penetration at a global level will continue to make mHealth services and solutions possible, even in the most remote areas.

Non-profit organizations such as the mHealth Alliance and the World Healthcare Organization (WHO) advocate the increased use of mHealth, particularly in underserved communities where poor infrastructure, non-availability of experts and doctors, and lack of medical education have hampered the provision of healthcare. A key benefit of mHealth technologies, if not the most important one, is their ability to fulfill this unmet need and provide continuous healthcare at a distance.

Moreover, mHealth technologies such as dose reminders can improve healthcare outcomes and reduce complications in chronic conditions by optimizing treatment compliance. For instance, 95% of diabetic cases are estimated to be self-managed, and mobile and Bluetooth glucose sensors have been developed to help patients to optimize drug dosing, reducing the risk of non-compliance and improving life expectancy (Diabetes UK, 2009). Significant advances in devices, sensors, monitors and mobile applications (apps) have seen the development of cost-effective portable diagnostics to remotely manage and monitor disease.

The report "Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017" provides a comprehensive analysis of the mHealth landscape. The survey gathered experience and opinion on the use of mHealth, and insights on key trends for the present and future use of these technologies, particularly within the pharmaceutical industry.

In depth, this report provides the following analysis -

  • Provides an analytical review of the most important needs and trends driving, or preventing, the use of mHealth technologies. It utilizes extensive secondary and internal research, in addition to our proprietary industry survey, in which respondents were asked to rank the relative importance of various market drivers and restraints. Additional survey insights include key reasons preventing organizations from investing in mHealth initiatives, including views from experts based in different geographical markets.
  • Explores how mHealth solutions and services could be used to provide direct benefits for pharmaceutical companies, healthcare institutions, healthcare providers and patients. Additionally, it provides survey analyses of the most common areas where mHealth solutions are being utilized within the pharmaceutical value chain, and where these solutions will have the most impact in the near future.
  • Provides a detailed analysis of the most promising geographical markets for mHealth technologies from 2017 to 2021. It provides results from our industry survey, in which respondents were asked to identify the most promising emerging markets for mHealth solutions and services over the next five years.
  • Provides strategic considerations for the effective implementation of mHealth initiatives, based on the totality of our industry survey results and a range of secondary and internal research. These include broad guidelines for different aspects of the implementation process such as: workflow strategies, revenue model considerations, governance, monitoring and human resource strategies.

Scope

  • What are mHealth technologies? What is their place within the pharmaceutical industry?
  • How prevalent is the use of mHealth technologies in the pharmaceutical, healthcare and healthcare IT industries?
  • What are the main driving factors necessitating the use of mHealth? What is the relative importance of these factors?
  • What are the commercial benefits that the use of mHealth solutions and services can provide across the pharmaceutical value chain?
  • In which areas are organizations currently using mHealth, and where do they feel it will have the most impact in the next five years?
  • What are the main challenges associated with mHealth technologies? What is the relative importance of these factors across key geographical markets? For the organizations that do not yet utilize mHealth solutions, what specific reasons have led to this decision?
  • What is the likelihood that organizations that already use mHealth will increase their investment within the next five years? Will those that do not currently invest in the technology begin doing so over this period?
  • How can mHealth initiatives be effectively implemented within an organization?
  • What is the overall opinion of industry experts on the use of mHealth technologies?

Key Reasons to Purchase

  • Gain insightful analyses and comprehensive understanding of mHealth technologies
  • Understand the key drivers necessitating the use of mHealth and the main barriers to implementation
  • Understand the views of 65 different organizations within the industry on mHealth
  • Assess the most relevant uses of mHealth solutions and services within your company, and effective ways of implementing mHealth initiatives

Table of Contents

1 Table of Contents

1 Table of Contents 4

1.1 List of Tables 6

1.2 List of Figures 6

2 mHealth Technologies Overview 8

2.1 What are mHealth Technologies? 8

2.2 What Types of Services Can mHealth Technologies Provide? 9

2.3 What are the Main Objectives of mHealth Technologies? 9

2.4 Key Stakeholders Involved in the Funding and Provision of mHealth 10

2.5 Key Market Segments in the mHealth Market Space 12

2.5.1 Key Sub-segments of the Global mHealth Market 14

2.6 How Prevalent is the Use of mHealth Technologies by Healthcare Organizations? Results from Our Industry-Wide Survey 15

3 The Global mHealth Market: The Most Important Drivers and Restraints in 2017 18

3.1 What Are the Most Important Growth Drivers in the Global mHealth Market? - Results from our Industry-Wide Survey 18

3.1.1 Providing Cost-Effective Care to Patients through mHealth Solutions 19

3.1.2 Can the Value and Effectiveness of Treatments be Demonstrated through mHealth Solutions? 19

3.1.3 How Interested Are HCPs and Reimbursement Entities in mHealth? 20

3.1.4 Accelerated Penetration of Mobile Technology at a Global Level 20

3.1.5 mHealth Solutions Helping Pharma Companies Solve Gaps in R&D Productivity 20

3.1.6 Is Government Funding and Support for mHealth in Key Markets Making a Difference? 21

3.1.7 Other Important Growth Drivers in the mHealth Market in 2017 21

3.1.8 What Are the Most Important Growth Drivers in the mHealth Market by Region? Results from our Industry-Wide Survey 22

3.2 What Are the Main Restraints in the Global mHealth Market? Results from our Industry-Wide Survey 23

3.2.1 What Are the Main Data Security and Privacy Concerns that Currently Surround mHealth Technologies? 24

3.2.2 Need for Clear and Harmonized Regulatory Frameworks for mHealth 24

3.2.3 Reluctance of Healthcare Professionals in Adopting New Technologies 26

3.2.4 How Much Evidence is there Documenting the Benefits of mHealth Technologies? 26

3.2.5 Is there a Shortage of Skilled IT Professionals in the Healthcare Industry? 27

3.2.6 What Are the Particular Reasons Specific Organizations Have Not Invested in mHealth Initiatives? Results from our Industry-Wide Survey 27

4 mHealth: Transforming Pharma R&D and Commercial Strategy 30

4.1 The role of mHealth Technologies in the Pharmaceutical Industry 30

4.1.1 What Specific Opportunities do mHealth Solutions Represent for Pharma Companies? Results from our Industry-Wide Survey 30

4.2 In Which Specific Areas Do Organizations Currently Utilize mHealth Technology? Results from our Industry-Wide Survey 32

4.2.1 Linking Early Research with Patient Data through Mobile Solutions 33

4.2.2 Will mHealth Technologies Solve the Patient Recruitment Bottleneck in Clinical Trials? 34

4.2.3 Improving Patient Compliance, Retention and Monitoring in Clinical Trials Through mHealth Solutions 35

4.2.4 How Will mHealth Solutions Improve Health Economic Analysis and Payer Engagement? 37

4.2.5 mHealth Opportunities for the Pharmaceutical Industry Beyond R&D 38

4.3 In Which Areas Will mHealth Have the Greatest Impact for Pharma Companies Over the Next Five Years? Results from our Industry-Wide Survey 41

5 The Most Promising Geographical Markets for mHealth Technologies in 2017 43

5.1 Important Trends in Mobile Penetration at a Global Level and Their Impact in Key mHealth Markets 43

5.2 Will Emerging Economies Continue to Be the Primary Drivers of Growth in the mHealth Market? 43

5.2.1 Which Emerging Economy Will Represent the Highest Revenue-Generating Market for mHealth Solutions and Services Over the Next Five Years? Results from our Industry-Wide Survey 44

5.2.2 Opportunities and Challenges in the Chinese mHealth Market in 2017 45

5.2.3 Opportunities and Challenges in the Indian mHealth Market in 2017 45

5.2.4 Opportunities and Challenges in the South Korean mHealth Market in 2017 46

5.2.5 Opportunities and Challenges in the Brazilian mHealth Market in 2017 46

5.2.6 Barriers to mHealth Implementation in Emerging Economies 46

6 Strategic Considerations for Effective Implementation of mHealth Initiatives 48

6.1 What Are the Most Important Factors to Consider when Designing a New mHealth Initiative? Results from our Industry-Wide Survey 48

6.1.1 Understanding Consumer Trends for New mHealth Initiatives 49

6.1.2 Considering Technological Trends for New mHealth Initiatives 49

6.1.3 Macroeconomic Trends Important for mHealth Initiatives 49

6.1.4 Security and Intellectual Property Considerations for mHealth Initiatives 49

6.1.5 Deploying an Effective Marketing Strategy for mHealth Initiatives 50

6.1.6 Channel Analysis for mHealth Initiatives 50

6.2 Other Important Considerations for Companies Designing mHealth Initiatives 51

7 Conclusions and Future Outlook for mHealth Technologies Beyond 2017 52

7.1 Some 96% of Organizations that Already Implement mHealth Solutions Are Likely to Increase Their Investment Within the Next Five Years 53

7.2 Which Regions Will Receive the Highest Investments in mHealth in the Next Five Years? Results from our Industry 54

8 Appendix 55

8.1 GBI Industry Survey: Breakdown of Respondents by Industry 55

8.2 GBI Industry Survey: Breakdown of Respondents by Region 55

8.3 GBI Industry Survey: Proportion of Organizations that Currently Implement mHealth Solutions 56

8.4 GBI Industry Survey: mHealth Utilization Rates by Region, Comparison of Expert Panels from Europe, North America and Asia 56

8.5 GBI Industry Survey: Most Important Factors Driving Growth in the mHealth Market 57

8.6 GBI Industry Survey: Most Important Factors Driving Growth in the mHealth Market, North American Panel vs European Panel vs Asian Panel 57

8.7 GBI Industry Survey: Main Factors Restraining Growth in the mHealth Market 58

8.8 GBI Industry Survey: Reasons Preventing Organizations from Investing in mHealth Initiatives 58

8.9 GBI Industry Survey: Reasons Preventing Organizations from Investing in mHealth Initiatives, North American Panel vs European Panel 59

8.10 GBI Industry Survey: Impact of mHealth Technologies on Pharmaceutical Companies, Panel of Organizations Implementing mHealth Solutions 59

8.11 GBI Industry Survey: Most Common Areas Where mHealth Solutions Are Used, Pharmaceutical Companies Panel 60

8.12 GBI Industry Survey: Areas Where mHealth Will Have the Most Impact for Pharmaceutical Companies Over the Next Five Years, Pharmaceutical Organizations Panel 60

8.13 GBI Industry Survey: Most Promising Emerging Markets for mHealth Solutions and Services (%), 2017-2021 61

8.14 GBI Industry Survey: Panel of Organizations Already Implementing mHealth Solutions, Most Important Factors to Consider when Designing a New mHealth Initiative 61

8.15 GBI Industry Survey: Organizations Already Implementing mHealth vs Organizations Not Currently Implementing mHealth, Likelihood of Surveyed Organizations Increasing Investment in the Sector (%), 2017-2021 62

8.16 GBI Industry Survey: Likelihood of Surveyed Organizations Increasing Investment in the Sector (%), 2017-2021, North American Panel vs European Panel vs Asian Panel 62

8.17 References 63

8.18 Contact Us 67

8.19 Disclaimer 67

1.1 List of Tables

Table 1: eHealth: Key Branches and Descriptions 8

Table 2: Examples of Important mHealth Services Currently Available 9

Table 3: FDA Guidance on Mobile Medical Applications by Subset 25

Table 4: Pharmaceutical mHealth Solutions Supporting Marketing and Patient Educational Efforts 39

Table 5: mHealth Solutions Supporting Drug Anti-counterfeiting Efforts 40

Table 6: mHealth Solutions Supporting Pharmaceutical Post-Marketing Surveillance Efforts 40

Table 7: Smartphone Penetration Rates in Key Geographical Markets (%), 2016 and 2020 44

Table 8: Important Considerations and Recommendations For Companies Designing mHealth Initiatives 51

1.2 List of Figures

Figure 1: Key Stakeholders in the Provision of Funding to Drive mHealth 11

Figure 2: Key Market Segments in the mHealth Market Space 13

Figure 3: GBI Research Industry Survey, Breakdown of Respondents by Industry 15

Figure 4: GBI Research Industry Survey, Breakdown of Respondents by Region 15

Figure 5: GBI Research Industry Survey, Proportion of Organizations that Currently Utilize mHealth Solutions 16

Figure 6: GBI Research Industry Survey, mHealth Utilization Rates by Region, North American Panel vs European Panel vs Asian Panel 16

Figure 7: GBI Industry Survey, Most Important Factors Driving Growth in the mHealth Market 18

Figure 8: GBI Industry Survey, North American Panel vs European Panel vs Asian Panel, Most Important Factors Driving Growth in the mHealth Market 22

Figure 9: GBI Industry Survey, Main Factors Restraining Growth in the mHealth Market 23

Figure 10: GBI Industry Survey, Reasons Preventing Organizations from Investing in mHealth Initiatives 27

Figure 11: GBI Industry Survey, North American Panel vs European Panel, Reasons Preventing Organizations from Investing in mHealth Initiatives 28

Figure 12: GBI Industry Survey, Impact of mHealth Technologies on Pharmaceutical Companies, Panel of Organizations Implementing mHealth Solutions 30

Figure 13: GBI Industry Survey, Most Common Areas Where mHealth Solutions Are Used, Pharmaceutical Companies Panel 32

Figure 14: Areas Where Pharma Can Optimize the Internal Pharma Value Chain 33

Figure 15: Examples of Sensor Suites Available for Different Therapeutic Areas 37

Figure 16: Examples of Sensor Suites Available for Different Therapeutic Areas 38

Figure 17: GBI Industry Survey, Areas Where mHealth Will Have the Most Impact for Pharmaceutical Companies Over the Next Five Years, Pharmaceutical Organizations Panel 41

Figure 18: GBI Industry Survey, Most Promising Emerging Markets for mHealth Solutions and Services (%), 2017-2021 45

Figure 19: GBI Industry Survey, Panel of Organizations Already Implementing mHealth Solutions, Most Important Factors to Consider when Designing a New mHealth Initiative 48

Figure 20: GBI Industry Survey, Organizations Already Implementing mHealth vs Organizations Not Currently Implementing mHealth, Likelihood of Surveyed Organizations Increasing Investment in the Sector (%), 2017-2021 53

Figure 21: GBI Industry Survey, North American Panel vs European Panel vs Asian Panel, Likelihood of Surveyed Organizations Increasing Investment in the Sector (%), 2017-2021 54

Figure 22: GBI Research Industry Survey, Breakdown of Respondents by Industry 55

Figure 23: GBI Research Industry Survey, Breakdown of Respondents by Region 55

Figure 24: GBI Research Industry Survey, Proportion of Organizations that Currently Utilize mHealth Solutions 56

Figure 25: GBI Research Industry Survey, mHealth Utilization Rates by Region, North American Panel vs European Panel vs Asian Panel 56

Figure 26: GBI Industry Survey, Most Important Factors Driving Growth in the mHealth Market 57

Figure 27: GBI Industry Survey, North American Panel vs European Panel vs Asian Panel, Most Important Factors Driving Growth in the mHealth Market 57

Figure 28: GBI Industry Survey, Main Factors Restraining Growth in the mHealth Market 58

Figure 29: GBI Industry Survey, Reasons Preventing Organizations from Investing in mHealth Initiatives 58

Figure 30: GBI Industry Survey, North American Panel vs European Panel, Reasons Preventing Organizations from Investing in mHealth Initiatives 59

Figure 31: GBI Industry Survey, Impact of mHealth Technologies on Pharmaceutical Companies, Panel of Organizations Implementing mHealth Solutions 59

Figure 32: GBI Industry Survey, Most Common Areas Where mHealth Solutions Are Used, Pharmaceutical Companies Panel 60

Figure 33: GBI Industry Survey, Areas Where mHealth Will Have the Most Impact for Pharmaceutical Companies Over the Next Five Years, Pharmaceutical Organizations Panel 60

Figure 34: GBI Industry Survey, Most Promising Emerging Markets for mHealth Solutions and Services (%), 2017-2021 61

Figure 35: GBI Industry Survey, Panel of Organizations Already Implementing mHealth Solutions, Most Important Factors to Consider when Designing a New mHealth Initiative 61

Figure 36: GBI Industry Survey, Organizations Already Implementing mHealth vs Organizations Not Currently Implementing mHealth, Likelihood of Surveyed Organizations Increasing Investment in the Sector (%), 2017-2021 62

Figure 37: GBI Industry Survey, North American Panel vs European Panel vs Asian Panel, Likelihood of Surveyed Organizations Increasing Investment in the Sector (%), 2017-2021 62

Back to Top